Stephen Wilton
Net worth: 75 540 $ as of 31/05/2026
Net worth: 75 540 $ as of 31/05/2026
Stephen Wilton is currently an Independent Director at BioSyent, Inc. since 2014.
Formerly, Mr. Wilton was Executive Director-Business Development at AstraZeneca Pharmaceuticals LP from 1993 to 2010 and Vice President-Pharmacy Affairs at The Canadian Association of Chain Drug Stores from 2011 to 2012.
Education includes an undergraduate degree from the University of Toronto and an MBA from The Schulich School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOSYENT INC. 0.06% | 24/03/2026 | 7,435 ( 0.06% ) | 75 540 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| BIOSYENT INC. | Director/Board Member | 16/01/2014 |
| Companies | Position | End |
|---|---|---|
The Canadian Association of Chain Drug Stores | Corporate Officer/Principal | 01/01/2012 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | General Counsel | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
BioSyent, Inc.
BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
The Canadian Association of Chain Drug Stores | |
The Schulich School of Business
The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions